Literature DB >> 30515259

Study on the association between vitamin D receptor gene fokI (T/C) polymorphisms and the susceptibility to type 2 diabetic kidney disease of Han nationality in south of China.

Xia Dong1, Dan Yang1, Rui Han1, Wei Yang1, Wei Pang1, Dianping Song1, Rou Shi1.   

Abstract

AIMS: To investigate the distribution of vitamin D receptor fokI gene polymorphism in Yunnan Han population, and to explore the relationship between SNP of fokI and type 2 diabetic kidney disease.
METHODS: We included 276 individuals of Han population of Yunnan in this study: 91 type 2 diabetes patients without kidney disease (DM group), their duration of diabetes is more than 10 years, 89 type 2 diabetes patients with diabetic kidney disease (DKD group), their duration of diabetes is less than 10 years and 96 healthy controls (NC group). We compared the concentration of 25 hydroxy vitamin D in different groups and used taqman probe to detect the genotype and allele of fokI, then analysed the relationship between the polymorphisms of fokI and the susceptibility of diabetic kidney disease.
RESULTS: (1) NC group had a significantly higher plasma concentrations of 25 (OH) D than DKD group and DM group (P < 0.01); (2) 25 (OH) D and age, BMI, HbA1c, TG showed a weak negative correlation (P < 0.01); (3) Genotype of fokI showed no differences in DM group and DKD group, same as in DM group and NC group; FF genotype in DKD group is relatively lower than NC group (P < 0.05), and there is no difference in Ff and ff genotype (P > 0.05); In DKD group, f allele was 53.4%, higher than DM group (RR = 1.46, P < 0.05); (4) Logistic regression analysis showed that ff genotype may be a susceptible factor for DKD (P = 0.04, OR = 2.37).
CONCLUSION: FokI Ff genotype accounted for a larger proportion of the Han population in Yunnan, and ff genotype may be a susceptible factor for DKD in Yunnan Han population.

Entities:  

Keywords:  Single nucleotide polymorphism; calcitriol; diabetes mellitus; diabetic kidney disease; receptor

Year:  2018        PMID: 30515259      PMCID: PMC6261924     

Source DB:  PubMed          Journal:  Int J Mol Epidemiol Genet        ISSN: 1948-1756


  27 in total

1.  Beyond proteinuria: VDR activation reduces renal inflammation in experimental diabetic nephropathy.

Authors:  Maria-Dolores Sanchez-Niño; Milica Bozic; Elizabeth Córdoba-Lanús; Petya Valcheva; Olga Gracia; Merce Ibarz; Elvira Fernandez; Juan F Navarro-Gonzalez; Alberto Ortiz; Jose Manuel Valdivielso
Journal:  Am J Physiol Renal Physiol       Date:  2011-12-14

2.  The World Health Organisation needs to reconsider its definition of health.

Authors:  R Saracci
Journal:  BMJ       Date:  1997-05-10

3.  Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial.

Authors:  Dick de Zeeuw; Rajiv Agarwal; Michael Amdahl; Paul Audhya; Daniel Coyne; Tushar Garimella; Hans-Henrik Parving; Yili Pritchett; Giuseppe Remuzzi; Eberhard Ritz; Dennis Andress
Journal:  Lancet       Date:  2010-11-06       Impact factor: 79.321

4.  Altered vitamin D metabolism in type II diabetic mouse glomeruli may provide protection from diabetic nephropathy.

Authors:  Y Wang; J Zhou; A W Minto; B K Hack; J J Alexander; M Haas; Y C Li; C W Heilig; R J Quigg
Journal:  Kidney Int       Date:  2006-07-05       Impact factor: 10.612

5.  [The association between vitamin D deficiency and diabetic nephropathy in type 2 diabetic patients].

Authors:  Dong-mei Li; Ying Zhang; Bo Ding; Bing-li Liu; Lan-lan Jiang; Chang-ying Xing; Jian-hua Ma
Journal:  Zhonghua Nei Ke Za Zhi       Date:  2013-11

6.  Impaired microvascular endothelial function in vitamin D-deficient diabetic nephropathy patients.

Authors:  S Munisamy; M D Kamaliah; A H Suhaidarwani; W M Zahiruddin; A H Rasool
Journal:  J Cardiovasc Med (Hagerstown)       Date:  2013-06       Impact factor: 2.160

Review 7.  Risk factors in diabetic nephropathy progression at present.

Authors:  D Lizicarova; B Krahulec; E Hirnerova; L Gaspar; Z Celecova
Journal:  Bratisl Lek Listy       Date:  2014       Impact factor: 1.278

8.  25 (OH) vitamin D levels and renal disease progression in patients with type 2 diabetic nephropathy and blockade of the renin-angiotensin system.

Authors:  Gema Fernández-Juárez; José Luño; Vicente Barrio; Soledad García de Vinuesa; Manuel Praga; Marian Goicoechea; Vicente Lahera; Luisa Casas; Jesús Oliva
Journal:  Clin J Am Soc Nephrol       Date:  2013-10-17       Impact factor: 8.237

Review 9.  Role of vitamin D in the pathogenesis of type 2 diabetes mellitus.

Authors:  X Palomer; J M González-Clemente; F Blanco-Vaca; D Mauricio
Journal:  Diabetes Obes Metab       Date:  2008-03       Impact factor: 6.577

10.  Interactions between serum vitamin D levels and vitamin D receptor gene FokI polymorphisms for renal function in patients with type 2 diabetes.

Authors:  Keitaro Yokoyama; Akio Nakashima; Mitsuyoshi Urashima; Hiroaki Suga; Takeshi Mimura; Yasuo Kimura; Yasushi Kanazawa; Tamotsu Yokota; Masaya Sakamoto; Sho Ishizawa; Rimei Nishimura; Hideaki Kurata; Yudo Tanno; Katsuyoshi Tojo; Shigeru Kageyama; Ichiro Ohkido; Kazunori Utsunomiya; Tatsuo Hosoya
Journal:  PLoS One       Date:  2012-12-04       Impact factor: 3.240

View more
  1 in total

Review 1.  Vitamin D Receptor gene polymorphisms and susceptibility to type 2 diabetes: evidence from a meta-regression and meta-analysis based on 47 studies.

Authors:  Surendar Aravindhan; Mohammed Fadhil Mohammed Almasoody; Nihad Abdallah Selman; Alekhina Natalia Andreevna; Sahithya Ravali; Payam Mohammadi; Mohammad Masoud Eslami; Bahman Razi; Saeed Aslani; Danyal Imani
Journal:  J Diabetes Metab Disord       Date:  2021-01-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.